Veterinary surgeon tests an experimental imaging technology on dogs being treated for cancer
By: Genevieve Rajewski, Tufts University
May 14, 2018
Up until October 2017, Dutchess's worst health issue was an accidental collision with a tree while chasing a squirrel. So the eight-year-old rescue dog's owner, Lisa Correa, was shocked when a wellness exam at Tufts at Tech Community Veterinary Clinic in Worcester turned up a sign of a serious problem. "They told me they found a lump on her left mammary gland," said Correa. "And my world pretty much came crashing down."
Health-Care Deals Jump in First Half
Wall Street Journal PRO: Venture Capital
By: Brian Gormley
July 13, 2017
Growing medical-device and medical-software investment propelled U.S. health-care venture-capital funding to $8.84 billion in the first half, a 27% jump from the $6.95 billion deployed in the first six months of last year, industry data show.
Health-care venture funding last quarter reached $3.65 billion across 221 rounds, a 9% increase from the $3.34 billion spread across 211 deals in the same period of 2016, according to market tracker Dow Jones VentureSource.
A Better Taste Of Your Own Medicine
By: Zach Ruskin
July 12, 2017
When deciding which flower to purchase, cannabis consumers face information overload. You have to consider a strain’s given effects, its THC and CBD content, the origin of the plant, and the tons of fine print affixed to each jar or baggie. However, despite the myriad details available, most people are still swayed by the tried-and-true metrics of weed smoking: smell and taste.
How flower smells and tastes is a huge selling point. That’s why the team behind Yofumo — a new device geared to the post-harvest process — is ready to help the industry make some serious dough.
The Art of Cured Cannabis: Can Pot Be Aged Like Wine and Whiskey?
By: Joel Warner
June 15, 2017
Yofumo aims to revolutionize the final step of the marijuana cultivation cycle and the part that’s still stuck in the pre-legalization dark ages: Curing, the process of removing all excess moisture from the buds after they’ve been harvested. While marijuana-growing facilities are now packed with cutting-edge cultivation technologies, most commercial and home growers still cure their weed by sticking it in sealed jars or buckets that are aired out every now and then and leaving it there for several weeks or months.
TERM SHEET — TUESDAY, JUNE 13
By: Erin Griffith
June 13, 2017
Yofumo Technologies, a Denver, Colo.-based cannabis storage and processing manufacturer, raised $1.5 million in seed funding. MedScience Ventures led the round.
Yofumo Raises $1.5M in Seed Funding
June 13, 2017
Yofumo Technologies, a Denver, CO-based company focused on refining all aspects of cannabis post-harvest drying, curing, transportation, specialty processing, and long and short-term storage, closed a $1.5m seed funding round.The round was led by MedScience Ventures with participation from other angel investors.
Led by Alfonso Campalans, CEO, Yofumo provides cannabis patent-pending post-harvest systems which use gaseous ozone to kill harmful microbials, including bacteria, mold and yeast, while ensuring the cannabinoid and terpene profiles are not negatively impacted.
BIODIRECTION RAISES $2M FOR CONCUSSION DEVICE
April 10, 2017
BioDirection said today it raised $2 million in interim financing to support the clinical development of its Tbit point-of-care blood test for concussion diagnosis.
The round was joined by Provident Healthcare Capital, MedScience Ventures and others, the Boston-based company said. The financing round brings the total raised for the company up to approximately $12 million.
“BioDirection’s Tbit System is a truly disruptive technology with the potential to dramatically improve the diagnosis of concussions and other TBIs. It will support diagnosis with the potential to dramatically lower both costs and time-to-treatment for patients and healthcare providers. It is rare that an emerging medical technology company can address a global unmet medical need of this scope, and the business objectives of our partners perfectly align with those of BioDirection,” MedScience Ventures founder Bret Siarkowski said in a press release.
BioDirection, Inc. Closes $2 Million Interim Financing
April 10, 2017
BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of concussions and other acquired traumatic brain injuries, today announced that the company has closed a $2 million interim financing to support clinical development of the Tbit™ System, the first technology positioned to deliver a rapid andobjective point-of-care blood test for concussion diagnosis.
Participants in the financing include Provident Healthcare Capital, a healthcare focused growth-equity fund, MedScience Ventures, LLC, a U.S./Asia-based fund focused on emerging life science and medical technologies, and other globally recognized leaders in medical technology investment. With this financing, total outside funds raised by BioDirection since the company was founded in 2010 are approximately $12 million...
Newly Formed MedScience Ventures Makes Trio of Deals
Wall Street Journal
By: Brian Gormley
February 6, 2017
Newly formed MedScience Ventures has held a first closing on a debut fund and financed a trio of startups formed to tackle medical needs such as preventing infections, screening for skin disorders and handling medicinal cannabis.
Boston-based MedScience formed last year and raised just under $5 million in an initial closing of its first fund in mid-2016. The team expects to raise as much as $10 million for the partnership, MedScience Ventures LP, by July 1. Investors in the fund include the firm’s general partners as well as individuals and family offices....